Abstract
AbstractVirtual reality (VR) technology can be a supporting tool to enhance mindfulness. Recently, many research using VR-based mindfulness (VBM) has been carried out in various psychiatric disorders but not in psychosis. We investigated safety and effects of virtual reality-based mindfulness (VBM) in patients with psychosis as a pilot study. Sixty-four patients were randomly assigned to VBM or to VR control. For VBM, education and meditation videos were provided. For VR control, 3-dimensional natural scenes were shown. Both programs consisted of 8 weekly sessions, each lasting about 30 min. Pre- and post-assessments were performed using the experiences questionnaire (EQ), psychotic symptom rating scales-delusion (PSYRATS-D), PSYRATS-auditory hallucinations (AH), motivation and pleasure scale-self rating (MAP-SR) and etc. The safety questionnaire was also surveyed after 1st and 8th session. Physiological measures such as skin conductance level (SCL), heart rate (HR) and RR interval, were collected during the VR interventions. Limited individuals participated in the safety questionnaire and physiological measures. All the results were presented in mean and standard deviation. We did not observe significant results in group x time interaction and main effects of group and time in the decentering and clinical scales. However, within group comparison showed that patients randomized to VBM showed increased decentering (p = 0.029) and decreased amount (p = 0.032) and duration of preoccupation (p = 0.016) in the PSYRATS-D. For the feelings and motivations about close caring relationships of the MAP-SR, we observed a significant group x time interaction (p = 0.027). The frequency of VR sickness was high but its severity was mild. There were significant differences only in HR over time in the VBM group (p = 0.01). These results suggest that VBM was not more effective in reducing decentering and psychiatric symptoms than VR control but its adversity was modest.
Funder
Ministry of Health and Welfare
Korea Health Industry Development Institute
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Cieślik, B. et al. Virtual reality in psychiatric disorders: A systematic review of reviews. Complement Ther. Med. 52, 102480 (2020).
2. Amista, N. F., Kim, J. J. & Kim, N. Trend and future of virtual reality for addiction treatment of substance use disorders: A systematic review. J. Digit. Contents Soc. 18, 1551–1560 (2017).
3. Miloff, A. et al. Automated virtual reality exposure therapy for spider phobia vs. in-vivo one-session treatment: A randomized non-inferiority trial. Behav. Res. Ther. 118, 130–140 (2019).
4. Gonçalves, R., Pedrozo, A. L., Coutinho, E. S., Figueira, I. & Ventura, P. Efficacy of virtual reality exposure therapy in the treatment of PTSD: a systematic review. PLoS One. 7, e48469 (2012).
5. Maples-Keller, J. L., Bunnell, B. E., Kim, S. J. & Rothbaum, B. O. The use of virtual reality technology in the treatment of anxiety and other psychiatric disorders. Harv. Rev. Psychiatry 25, 103–113 (2017).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献